financetom
ASND
financetom
/
Healthcare
/
ASND
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Ascendis Pharma A/SASND
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs.

It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia.

In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/" for systemic delivery.

The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Latest News >
Australia's sovereign wealth fund tops $166 billion, reduces US portfolio
Australia's sovereign wealth fund tops $166 billion, reduces US portfolio
Sep 8, 2025
SYDNEY (Reuters) - Australia's sovereign wealth fund, the Future Fund, said on Tuesday its valuation had reached A$252 billion ($166.22 billion) as it pared back its U.S. market exposure to boost investments in Germany and Japan. The fund delivered a 12.2% return in the year ended June 30, which the Future Fund said was double its government-mandated target of 6.1%....
GLOBAL MARKETS-Stocks rise as prospect of Fed easing trumps political uncertainty
GLOBAL MARKETS-Stocks rise as prospect of Fed easing trumps political uncertainty
Sep 8, 2025
* Stocks get lift from Fed easing expectations * Investors mull 50bp cut, look to U.S. CPI, PPI releases for clues * Political turmoil in many countries complicates outlook for FX, bond markets By Rae Wee SINGAPORE, Sept 9 (Reuters) - Asia stocks rose on Tuesday, buoyed by expectations of a U.S. rate cut as early as next week, even...
US agency launches process to bar some Chinese labs from testing US electronics
US agency launches process to bar some Chinese labs from testing US electronics
Sep 8, 2025
WASHINGTON, Sept 8 (Reuters) - The Federal Communications Commission on Monday said it has begun proceedings to withdraw recognition from seven test labs owned or controlled by the Chinese government, citing U.S. national security concerns. The U.S. telecom agency in May voted to finalize rules barring Chinese labs deemed risks to U.S. national security from testing electronic devices such as...
Japanese bonds rally as yields near historic highs lure buyers
Japanese bonds rally as yields near historic highs lure buyers
Sep 8, 2025
TOKYO, Sept 9 (Reuters) - Japanese government bonds (JGBs) rallied on Tuesday, as long-term yields at historic highs drew buyers and diminished hopes for central bank rate hikes supported shorter-dated securities. The benchmark 10-year JGB yield fell 1.5 basis points (bps) to 1.550%. The 30-year yield lost 3.5 bps to 3.245%, down from Monday's 3.285% that matched the all-time high...
Copyright 2023-2026 - www.financetom.com All Rights Reserved